FDA approves GSK RSV vaccine for adults 50 to 59
The FDA's expanded approval could help GSK maintain its dominance in the RSV market, which includes shots from Pfizer and Moderna.
Source: cnbc.com
Luke Miels News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Luke Miels. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Luke Miels Today - Breaking & Trending Today
GSK's New Vaccine Kept the Boss in Her Job — and an Activist at Bay
(Bloomberg) -- When Elliott Investment Management came calling for the ouster of Emma Walmsley, the chief executive officer of GSK Plc found her remedy in a product almost 60 years in the making.Most Read from BloombergHims Debuts $199 Weight-Loss Shots at 85% Discount to WegovyIran State TV Says ‘No Sign of Life’ at Helicopter Crash SiteJamie Dimon Says Succession at JPMorgan Is ‘Well on the Way’One of the Last Big Bears on Wall Street Turns Bullish on US StocksFlorida’s 125% Surge in Property-
Source: yahoo.com
Investegate | Company Announcement
Investegate announcements from Director/PDMR Shareholding - Replacement
Source: investegate.co.uk
GSK plc (NYSE:GSK) Q4 2023 Earnings Call Transcript
GSK plc misses on earnings expectations. Reported EPS is $0.72 EPS, expectations were $0.76.
Source: insidermonkey.com